Nascent Biotech Inc.: Nascent Biotech Receives Notice of the

VERO BEACH, FL / ACCESSWIRE / November 1, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company who develops monoclonal antibodies

Related Keywords

United States , Sean Carrick , Exchange Commission , Trademark Office , Nascent Biotech Inc , Securities Exchange , Nascent Biotech Inc Form , Nascent Biotech Inc View , Nascent Biotech , United States Patent , Securities Act , Securities Exchange Act , Private Litigation Reform Act , Nascent , Iotech , Eceives , Otice , Ssuance , Atent ,